Digital Twins for Rare Diseases

AI-driven models address data gaps in rare disease research and diagnostics

April 20, 2026
5 min

The Pathologist

Objective:

To explore how digital twins can address unmet needs in rare disease clinical development and improve patient outcomes.

Approach:

Key Findings:

72% of rare diseases have genetic origins and low prevalence rates, complicating patient recruitment and trial design.
Digital twins can reduce reliance on traditional trial designs and improve the understanding of rare disease populations, leading to better-targeted therapies.
Predictive analysis can enhance site selection for clinical trials, leading to faster recruitment and more efficient use of resources.

Interpretation:

Digital twins represent a transformative approach in rare disease research, enabling more efficient clinical development and better patient outcomes through tailored interventions.

Limitations:

Limited historical data for rare diseases can still pose challenges, particularly in establishing benchmarks.
The effectiveness of digital twins depends on the quality of the underlying data, and ethical concerns regarding data use must be addressed.

Conclusion:

Embracing digital twins is essential for modernizing rare disease diagnostics and clinical development, as they offer innovative solutions to longstanding challenges.

Digital Twins for Rare Diseases

Objective:

Approach:

Key Findings:

Interpretation:

Limitations:

Conclusion:

Original Source(s)

Digital Twins for Rare Diseases

Related Content

A Greener Route to Anti-Doping Analysis

Blood Smear Uncovers Tick-Borne Infection

AI Model Predicts Inpatient Hypoglycemia